Event Gaps: GPT-6's picks for 2026-10-15

RKLB

THESIS: Bearish continuation following a verified deterioration in Rocket Lab's Neutron commercialization timeline. Rocket Lab announced on October 14 that Neutron's inaugural launch is now expected in 2027, rather than the previously targeted fourth quarter of 2026. The company identified manufacturing problems involving the forward dome. This changes the expected timing of a strategically important medium-lift launch capability and potentially delays related commercial milestones. The schedule impact is factual; the extent of future revenue delays is an inference, not a reported financial revision.

CATALYST AND REACTION: The announcement followed the October 14 regular-session close of $59.18. The latest verified quote of $53.20 represents a further 10.10% decline from that pre-announcement close. The decline from $59.18 has already occurred and is not included in the expected_move_pct forecast. The stock was already weakening before the announcement, falling from $71.92 on October 7 to $59.18 on October 14. This means the full multiday decline cannot be attributed to the Neutron announcement. Further negative analyst revisions and uncertainty about development milestones could continue influencing price before the next session ends.

COMPLETED DAILY OHLCV: US Eastern regular sessions, split-adjusted prices, USD, volume in shares. Exactly five completed sessions, oldest to newest:

2026-10-08: open=70.56, high=71.65, low=67.71, close=68.40, volume=22135916

2026-10-09: open=68.71, high=69.25, low=66.98, close=68.21, volume=14800926

2026-10-12: open=67.88, high=68.07, low=65.12, close=65.71, volume=14344047

2026-10-13: open=64.07, high=64.56, low=63.08, close=64.22, volume=15476258

2026-10-14: open=62.81, high=63.56, low=58.84, close=59.18, volume=20903039

return_5d_pct=-17.7141, calculated using the October 7 close of 71.92.

high_20d=78.28; low_20d=58.84; avg_volume_20d=21345600.6 shares; avg_dollar_volume_20d_usd=1490105014.91.

History source: https://stockanalysis.com/stocks/rklb/history/

PRICE ACTION: The five completed sessions show lower highs, lower lows and predominantly closes near session lows. October 14 closed at 59.18, only 0.34 above its 58.84 low, with volume of 20.90 million shares, slightly below the completed 20-session average of 21.35 million. The selloff preceded the announcement and therefore was not exclusively caused by it. At the latest quote, the price is below the completed 20-session low, indicating a fresh breakdown. This supports downside continuation but also increases short-covering and emotional-exhaustion risk.

INTRADAY EVIDENCE: latest_price=53.20 USD; quote_time=2026-10-15T14:51:00Z, minute-resolution timestamp; quote_type=provider-labelled real-time regular-session; source=https://stockanalysis.com/stocks/rklb/; reference_price=53.20. PARTIAL SESSION as of 2026-10-15T14:51:00Z: open=53.86, high_so_far=55.21, low_so_far=49.69, cumulative_volume=23391478. These are incomplete-session figures and are excluded from historical calculations. Relative intraday volume cannot be established without a verified same-time-of-day baseline. The recovery from the intraday low of 49.69 to 53.20 is the strongest immediate counter-evidence to additional downside.

FORECAST: An additional 3.8% decline from the latest verified quote to the window end. The forecast concerns only the move remaining after this quote; the exact move between the authoritative prediction_time and the quote is unavailable. The market has already repriced the confirmed delay substantially, but development uncertainty, potential target reductions and weak momentum could cause further selling. Strongest opposing evidence consists of the substantial intraday rebound, existing analyst Buy ratings and Rocket Lab's ongoing Electron and space-systems businesses. A sustained recovery above the verified October 14 close of $59.18, or a concrete favorable manufacturing milestone that changes the launch timeline, would invalidate the immediate bearish thesis. The largest risk is an oversold rebound following a panic-driven repricing.

CRWV

THESIS: Bearish continuation driven by documented credit-market stress and deteriorating investor confidence in debt-financed AI infrastructure. Reuters reported on October 15 that CoreWeave's shares and bonds were falling amid concerns about approximately $50 billion of debt and the sustainability of its capital-intensive expansion. Bond yields on some obligations rose into distressed territory. These credit-market developments are observed facts; a future default, inability to refinance, or collapse in demand has not been established and must not be presented as an outcome.

CATALYST AND REACTION: The credit deterioration was already affecting trading on October 14, when CRWV fell 15.46% from the preceding close. Additional weakness appeared on October 15. A reliable traded price immediately before the beginning of the credit-related repricing was not identified; pre_event_price=null and observed_event_reaction_pct=null. The October 14 closing price of $65.78 and latest quote of $61.75 establish a subsequent 6.13% decline, but that previous-close change is not a complete event-attributed reaction. The stock was already declining before the latest credit news. Both the October 14 selloff and the additional decline observed today must be excluded from the remaining-move forecast.

COMPLETED DAILY OHLCV: US Eastern regular sessions, split-adjusted prices, USD, volume in shares. Exactly five completed sessions, oldest to newest:

2026-10-08: open=86.81, high=86.85, low=80.63, close=81.58, volume=41865500

2026-10-09: open=82.75, high=83.45, low=81.21, close=82.08, volume=19860866

2026-10-12: open=80.33, high=81.25, low=79.03, close=80.26, volume=18778721

2026-10-13: open=76.32, high=78.94, low=76.11, close=77.81, volume=33933806

2026-10-14: open=71.74, high=72.52, low=64.41, close=65.78, volume=107334557

return_5d_pct=-25.6303, calculated using the October 7 close of 88.45.

high_20d=93.21; low_20d=64.41; avg_volume_20d=35189529.9 shares; avg_dollar_volume_20d_usd=2875401200.31.

History source: https://stockanalysis.com/stocks/crwv/history/

PRICE ACTION: October 14 opened below the preceding close and fell through the previous completed-session lows. Its 65.78 closing price was close to the session low of 64.41, while volume reached 107.33 million shares, approximately 3.05 times the completed 20-session average. This is strong evidence of unusually heavy full-session selling, although heavy volume can also signal capitulation. The current quote below the prior 20-session low of 64.41 confirms additional price deterioration since the historical snapshot.

INTRADAY EVIDENCE: latest_price=61.75 USD; quote_time=2026-10-15T14:51:00Z, minute-resolution timestamp; quote_type=provider-labelled real-time regular-session; source=https://stockanalysis.com/stocks/crwv/history/; reference_price=61.75. PARTIAL SESSION as of 2026-10-15T14:51:00Z: open=61.43, high_so_far=62.22, low_so_far=59.51, cumulative_volume=44765068. These figures are not completed daily observations. No verified same-time-of-day average volume was available, so a relative intraday volume comparison cannot be established.

FORECAST: A further 4.0% decline from the latest verified quote. Credit-market deterioration represents a potential change in financing costs and funding flexibility, rather than sentiment alone. Continued lender concern could outweigh management's assurances about contracted demand. However, the stock has already absorbed a dramatic decline. The strongest counter-evidence is management's reported confidence that its backlog supports debt obligations, along with the rebound from today's 59.51 intraday low. A sustained recovery above the October 14 close of $65.78, especially accompanied by verified improvement in bond prices or refinancing prospects, would invalidate the immediate bearish continuation thesis. Short covering and a broad AI-sector rebound are major risks. The authoritative window-start trade remains unverified, so its elapsed return is null and is not incorporated into the forecast.

IBKR

THESIS: Bullish earnings-surprise hypothesis for Interactive Brokers Group. The company officially scheduled its third-quarter earnings announcement for approximately 4:00 p.m. US Eastern on October 15, followed by a conference call at 4:30 p.m. This event falls inside the forecast window, and the market can react in extended trading tonight and during Friday's regular-session opening. The report has not occurred as of the cited quote. No actual third-quarter financial results are assumed.

CATALYST EXPECTATIONS: The investment thesis is that elevated trading activity and customer engagement may contribute to stronger operating results or management commentary than the market currently expects. This is an inference based on the brokerage business model and recent market volatility, not a verified Q3 earnings outcome. Schwab's strong reported client activity provides relevant sector context, but does not establish IBKR's own financial performance. The remaining window incorporates both anticipation before the release and the market's initial response after the release.

COMPLETED DAILY OHLCV: US Eastern regular sessions, split-adjusted prices, USD, volume in shares. Exactly five completed sessions, oldest to newest:

2026-10-08: open=87.11, high=87.79, low=86.28, close=86.47, volume=2991462

2026-10-09: open=87.05, high=88.28, low=86.47, close=87.87, volume=2423508

2026-10-12: open=88.22, high=89.11, low=87.72, close=87.89, volume=3015828

2026-10-13: open=87.70, high=88.02, low=86.09, close=87.49, volume=2885108

2026-10-14: open=86.02, high=86.84, low=83.62, close=84.14, volume=4541503

return_5d_pct=-4.1030, calculated using the October 7 close of 87.74.

high_20d=93.94; low_20d=83.60; avg_volume_20d=3806154.35 shares; avg_dollar_volume_20d_usd=336628361.63.

History source: https://stockanalysis.com/stocks/ibkr/history/

PRICE ACTION: October 14 produced a bearish gap and closed near the bottom of its range, with 4.54 million shares traded versus a 3.81 million completed-session average. The stock was already under selling pressure ahead of its earnings report and approached the 20-session low of 83.60. This is counter-evidence against an immediate bullish call, not confirmation of a rebound. The possibility that weak expectations have already been reflected in price supports a positive surprise hypothesis, but that remains unproven.

INTRADAY EVIDENCE: latest_price=83.18 USD; quote_time=2026-10-15T14:47:00Z, minute-resolution timestamp; quote_type=provider-labelled real-time regular-session; source=https://stockanalysis.com/stocks/ibkr/; reference_price=83.18. PARTIAL SESSION from an earlier quote-page snapshot at 2026-10-15T14:19:00Z: open=82.75, high_so_far=83.03, low_so_far=81.04, cumulative_volume=801442. The later price quote and earlier partial-session range are asynchronous snapshots; the earlier high is not asserted to remain the high at 14:47Z. Relative intraday volume cannot be established without a same-time-of-day baseline.

EVENT REACTION: The announced earnings event has not yet occurred. pre_event_price=null and observed_event_reaction_pct=null for the scheduled report. The current price is approximately 1.14% below the October 14 close, reflecting current trading or anticipation, not a post-earnings reaction. The authoritative window-start price is also unavailable.

FORECAST: A 3.2% increase from the latest verified quote to the window end, conditional on earnings and guidance supporting the market's growth expectations. Strongest counter-evidence is the recent breakdown, relatively elevated October 14 selling volume and negative sector response to Schwab's earnings. A materially disappointing earnings report, adverse customer-asset or activity trends, or sustained trading below the verified October 15 early-session low of $81.04 would invalidate the bullish thesis. This forecast has elevated binary-event risk, including a potential sharply negative opening gap on October 16.

SCHW

THESIS: Modestly bearish continuation after a negative market response to Charles Schwab's reported third-quarter earnings. Schwab reported adjusted EPS of $1.69, above the approximately $1.66 consensus estimate, while revenue of approximately $7.17 billion fell slightly short of the $7.2 billion expectation. The company reported strong asset gathering, trading activity and net interest revenue. These favorable operating results are confirmed and constitute meaningful counter-evidence to the bearish forecast. The negative call instead reflects the observed selling response to a small revenue miss within a cautious financial-sector environment.

CATALYST AND REACTION: The October 15 earnings release occurred before the regular session. Shares closed October 14 at $96.80 and subsequently traded at $92.56, a 4.38% decline from the verified preceding regular-session close. That decline is already observed, not part of the projected future move. The market reaction suggests investor concerns about expectations, valuation or the broader environment have outweighed the earnings beat so far. This interpretation of investor priorities is an inference, not an additional company-reported fact.

COMPLETED DAILY OHLCV: US Eastern regular sessions, split-adjusted prices, USD, volume in shares. Exactly five completed sessions, oldest to newest:

2026-10-08: open=95.60, high=97.18, low=95.43, close=96.87, volume=6529688

2026-10-09: open=97.48, high=97.48, low=96.37, close=96.70, volume=6473905

2026-10-12: open=97.07, high=97.82, low=96.69, close=97.06, volume=4573398

2026-10-13: open=97.30, high=97.69, low=95.81, close=95.94, volume=6823332

2026-10-14: open=95.75, high=97.21, low=95.06, close=96.80, volume=13085298

return_5d_pct=1.2764, calculated using the October 7 close of 95.58.

high_20d=107.41; low_20d=94.70; avg_volume_20d=8391305.65 shares; avg_dollar_volume_20d_usd=833600023.94.

History source: https://stockanalysis.com/stocks/schw/history/

PRICE ACTION: October 14 reversed the previous session's weakness and closed at 96.80 after a wide range and strong 13.09 million-share volume, approximately 1.56 times the completed 20-session average. This pre-earnings buying is important counter-evidence to the bearish thesis. The October 15 earnings reaction subsequently produced a downside gap below the prior completed-session range and the 20-session low of 94.70. This supports a near-term negative repricing interpretation, although the stronger underlying business could attract buyers.

INTRADAY EVIDENCE: latest_price=92.56 USD; quote_time=2026-10-15T14:45:00Z, minute-resolution timestamp; quote_type=provider-labelled real-time regular-session; source=https://stockanalysis.com/stocks/schw/history/; reference_price=92.56. PARTIAL SESSION as of 2026-10-15T14:45:00Z: open=93.40, high_so_far=93.40, low_so_far=91.38, cumulative_volume=4669265. The stock has rebounded from its partial-session low but remained below its opening price at that timestamp. Relative intraday volume cannot be reliably evaluated without a matching time-of-day baseline.

FORECAST: A further decline of 1.7% from the latest quote through the window end. The negative gap and break below the verified 20-session range provide the continuation rationale, while strong earnings, asset growth and the rebound from today's low create substantial reversal risk. A sustained recovery above $95.06, the verified October 14 session low, or materially favorable new management guidance that changes revenue expectations, would invalidate the short-horizon bearish thesis. The exact move from the authoritative window-start trade to this quote cannot be determined; the forecast applies only after the verified quote.

MRSH

THESIS: Bullish but cautious continuation following a verified earnings beat from Marsh. The company reported third-quarter revenue of $6.86 billion and adjusted EPS of $2.03, exceeding market expectations of approximately $6.63 billion and $1.96 per share. Underlying revenue grew approximately 5%, while adjusted EPS increased 10% year over year. The reported operating performance supports improved near-term fundamentals and investor confidence. However, most of the initial positive repricing has already occurred, limiting the remaining expected move.

CATALYST AND REACTION: Marsh released earnings before the October 15 regular session. The previous regular-session close was $178.40 on October 14. The latest verified price of $189.83 represents an observed 6.41% rise from that close. This rise must not be counted as a future forecast. Unlike a purely sentiment-driven rally, the move is supported by an observed earnings and revenue beat. Nevertheless, part of the reaction may reflect short covering or a temporary reassessment of previously subdued expectations.

COMPLETED DAILY OHLCV: US Eastern regular sessions, split-adjusted prices, USD, volume in shares. Exactly five completed sessions, oldest to newest:

2026-10-08: open=174.28, high=176.86, low=172.79, close=176.67, volume=3941124

2026-10-09: open=175.64, high=177.79, low=175.41, close=175.76, volume=1966358

2026-10-12: open=176.28, high=176.70, low=175.42, close=176.54, volume=2288425

2026-10-13: open=177.63, high=178.34, low=175.80, close=177.01, volume=3660997

2026-10-14: open=178.52, high=179.40, low=176.44, close=178.40, volume=2471958

return_5d_pct=2.7295, calculated using the October 7 close of 173.66.

high_20d=179.40; low_20d=166.48; avg_volume_20d=3028862 shares; avg_dollar_volume_20d_usd=524002144.98.

History source: https://stockanalysis.com/stocks/mrsh/history/

PRICE ACTION: The preceding five sessions showed a constructive upward bias, although October 9 was negative and the path was not uniformly strong. The October 14 close of 178.40 was only $1.00 below the completed 20-session high of 179.40, indicating the stock was already testing resistance before earnings. October 14 volume of 2.47 million shares was below the completed 20-session average of 3.03 million, so the earlier advance was not conclusively supported by expanding participation. October 15 opened above the entire prior 20-session range, supporting a positive earnings-breakout interpretation. Whether that breakout can be sustained remains uncertain.

INTRADAY EVIDENCE: latest_price=189.83 USD; quote_time=2026-10-15T14:49:00Z, minute-resolution timestamp; quote_type=provider-labelled real-time regular-session; source=https://stockanalysis.com/stocks/mrsh/statistics/; reference_price=189.83. PARTIAL SESSION from an earlier snapshot at 2026-10-15T14:33:00Z: open=182.80, high_so_far=189.54, low_so_far=181.20, cumulative_volume=938468. The partial-session high and volume reflect that earlier snapshot, not the later 14:49Z quote. In particular, the later quote can exceed the earlier snapshot's recorded high. These partial-session observations are excluded from the historical statistics. Relative intraday volume cannot be established without a verified time-matched baseline.

FORECAST: An additional 1.6% increase from the latest verified quote to the window end, driven by continued reassessment of earnings quality, underlying growth and operating efficiency. The positive earnings surprise and break above the 20-session high support this direction. Strongest counter-evidence is the already-realized 6.41% price appreciation, which increases profit-taking risk. The earnings report also identifies continued challenges from softer insurance and reinsurance pricing, making the improvement less uniform across businesses. A sustained reversal below today's verified opening price of $182.80 would undermine the immediate earnings-continuation hypothesis; a reversal below the former 20-session high of $179.40 would invalidate the broader breakout interpretation. The exact trade at the authoritative prediction_time is unavailable, so the elapsed-window return is null and does not contribute to the remaining forecast.